The medical care providers channel has been the shining star of the professional skin care market for several years, registering double-digit growth in 2021 to reach $2.3 billion, according to our Medical Dispensing Skin Care: Global Market Brief report. While the COVID-19 pandemic caused physicians around the world to temporarily shutter their doors, opportunities nevertheless arose, resulting in an unprecedented global surge in sales of medical dispensed skin care brands.
Diversion is probably one of the most discussed topics in the professional skin care community with the majority of marketers facing this challenge. As the Internet has evolved as an important marketplace for everything beauty, a substantial number of professional skin care products—some of them counterfeit—are now sold through diverters on Amazon and eBay, undermining the intent of a company to sell authentic and high quality products through a reputable therapist, aesthetician, or physician.Continue reading
Industry buzz was across the board at this year’s AAD conference held in sunny Orlando, FL, as marketers, suppliers, and dermatologists converged to discuss emerging medical technologies, new treatments for skin conditions, and the impact of a new administration on the healthcare system. The exhibit hall showcased new products—both topical and devices. It was also a place where marketers chatted with us openly about areas like amalgamation of dermatologist groups and how to curtail diversion.
From a business standpoint, marketers acknowledged their frustrations with the diversion epidemic, which is rampant in this industry. Marketers spoke about the merits of Amazon’s new professional platform, but realized it has limitations as well. Other diversion-curbing platforms at the show were RegimenMD, which is slowly ramping up its physician bases of subscribers. The problem is an internal one as well, with marketers agreeing that they must do a better job of tracking sales to accounts who blatantly overorder.Continue reading
Hydroquinone-free products are among the most dynamic performers in the U.S. professional skin care market in 2014. Introduced by several leading manufacturers, non-hydroquinone-based products are driving sales in the hyperpigmentation/sun damage skin care concern category, which outperforms the total market growth in 2014, finds recently published report Professional Skin Care: U.S. Market Analysis and Opportunities.
While hydroquinone (HQ) has been the gold standard ingredient in the physician dispense arena for the treatment of hyperpigmentation, this ingredient is surrounded with controversy due to some of its reported side effects. Continue reading